Clinical Trial Update: Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PROSTVAC/TRICOM vaccine therapy with flutamide versus flutamide alone for prostate cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PROSTVAC/TRICOM vaccine therapy (PROSTVAC TRICOM vaccine)
• flutamide (flutamide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-11-26